Chris McKinnell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chris McKinnell has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- R. M. Sharpe
MRC Reproductive Biology Unit, Centre for Reproductive Biology, Edinburgh, Scotland, United Kingdom
2 shared publications - Rod Thomas Mitchell
Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh
2 shared publications - William Hamish B Wallace
The University of Edinburgh, Edinburgh, Scotland
2 shared publications C J H Kelnar
1 shared publicationChris J.H. Kelnar
Edinburgh Royal Hospital for Sick Children , 9 Sciennes Road, Edinburgh EH9 1LF , UK
1 shared publicationDriesche S van Den
1 shared publication
Latest Publications
- 1 March 2013
- Published by Bioscientifica in Endocrine Abstracts
- p. 1
Is diethylstilboestrol an endocrine disruptor in the developing human fetal testis? Effects of DES exposure using a xenograft approach
Context: In rodents, in-utero exposure to the exogenous oestrogen diethylstilboestrol (DES) results in reproductive abnormalities in male offspring. It has been proposed that similar anti-androgenic effects also occur in the human fetal testis following oestrogen exposure. Objective: Determine effects of DES exposure on testosterone production by normally growing human fetal testis xenografts. Design: Human fetal testes (15–19 weeks gestation, n=6) were xenografted into castrate male nude mice. Mice were treated for 35 days with vehicle or 100 μg/kg DES three times a week; all mice were treated with hCG to mimic normal human pregnancy. For comparison, fetal male rats were exposed in-utero to vehicle or 100 μg/kg DES on e13.5, e15.5, e17.5, e19.5 and e20.5. Main outcome measures: Testosterone production from xenografts was assessed by measuring host serum testosterone and seminal vesicle (SV) weights at termination. Insl3 production was determined in serum, whilst immunohistochemistry was performed for Insl3 and ERα. Results: Human fetal testis xenografts showed similar survival and total graft weight in DES and vehicle-exposed hosts. SV weight was significantly increased in DES compared to vehicle-exposed hosts (44.3 vs 26.6 mg, P=0.01) and testosterone was also increased (0.33 vs 0.45 ng/ml, P>0.05). There was no difference in Insl3 expression. In contrast, in-utero exposure of fetal rats to DES resulted in significantly lower intra-testicular testosterone levels associated with a reduction in Insl3 expression. ERα was expressed in fetal rat testis but was not expressed in the human fetal testis. Conclusions: Exposure of human fetal testes to DES does not impair testosterone production as it does in rats. This can be explained by a lack of ERα signalling in the human fetal testis. This highlights an important difference in the effect of proposed ‘endocrine disruptors’ in humans compared with rodents which has important implications for determining the risk posed to human health by environmental oestrogens. Declaration of funding: This work was supported by a BSPED Research award and an Academy of Medical Sciences Starter Grant for Clinical Lecturers.
- 1 March 2013
- Published by Bioscientifica in Endocrine Abstracts
- p. 1
Is diethylstilboestrol an endocrine disruptor in the developing human fetal testis? Effects of DES exposure using a xenograft approach
Context: In rodents, in-utero exposure to the exogenous oestrogen diethylstilboestrol (DES) results in reproductive abnormalities in male offspring. It has been proposed that similar anti-androgenic effects also occur in the human fetal testis following oestrogen exposure. Objective: Determine effects of DES exposure on testosterone production by normally growing human fetal testis xenografts. Design: Human fetal testes (15–19 weeks gestation, n=6) were xenografted into castrate male nude mice. Mice were treated for 35 days with vehicle or 100 μg/kg DES three times a week; all mice were treated with hCG to mimic normal human pregnancy. For comparison, fetal male rats were exposed in-utero to vehicle or 100 μg/kg DES on e13.5, e15.5, e17.5, e19.5 and e20.5. Main outcome measures: Testosterone production from xenografts was assessed by measuring host serum testosterone and seminal vesicle (SV) weights at termination. Insl3 production was determined in serum, whilst immunohistochemistry was performed for Insl3 and ERα. Results: Human fetal testis xenografts showed similar survival and total graft weight in DES and vehicle-exposed hosts. SV weight was significantly increased in DES compared to vehicle-exposed hosts (44.3 vs 26.6 mg, P=0.01) and testosterone was also increased (0.33 vs 0.45 ng/ml, P>0.05). There was no difference in Insl3 expression. In contrast, in-utero exposure of fetal rats to DES resulted in significantly lower intra-testicular testosterone levels associated with a reduction in Insl3 expression. ERα was expressed in fetal rat testis but was not expressed in the human fetal testis. Conclusions: Exposure of human fetal testes to DES does not impair testosterone production as it does in rats. This can be explained by a lack of ERα signalling in the human fetal testis. This highlights an important difference in the effect of proposed ‘endocrine disruptors’ in humans compared with rodents which has important implications for determining the risk posed to human health by environmental oestrogens. Declaration of funding: This work was supported by a BSPED Research award and an Academy of Medical Sciences Starter Grant for Clinical Lecturers.
- Open Access
- 2 June 2009
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 24 (9) , 2244-2254
Effect of fetal or neonatal exposure to monobutyl phthalate (MBP) on testicular development and function in the marmoset
Fetal exposure of male rats to some phthalates induces reproductive abnormalities, raising concerns for similar effects in humans. In order to address this in a more appropriate animal model, the aim of the present studies was to investigate the effect of fetal/neonatal exposure to monobutyl phthalate (MBP) in a non-human primate, the marmoset. In particular, to determine if exposure resulted in effects at birth, or in adulthood, similar to those in male rats, and whether there was evidence for induction of carcinoma-in-situ (CIS) or testicular germ cell tumours (TGCT). Pregnant female marmosets were dosed from ∼7–15 weeks gestation with 500 mg/kg/day MBP and male offspring studied at birth (1–5 days; n = 6) or in adulthood (n = 5). In another study, newborn males (n = 5 co-twins) were dosed with 500 mg/kg/day MBP for 14 days, commencing at ∼4 days of age. Fetal exposure of marmosets to MBP did not affect gross testicular morphology, reproductive tract development or testosterone levels at birth, nor were germ cell number and proliferation, Sertoli cell number or germ:Sertoli cell ratio affected. In two of six MBP-exposed animals, unusual clusters of undifferentiated germ cells were found, but their significance is unclear. Neonatal MBP treatment did not affect germ cell numbers or differentiation. Fetal exposure to MBP did not affect testis size/morphology, germ cell numbers or fertility in adulthood. There was no evidence for CIS or TGCT. Fetal exposure of marmosets to MBP does not measurably affect testis development/function or cause testicular dysgenesis, and no effects emerge by adulthood. Some effects on germ cell development were found, but these were inconsistent and of uncertain significance.
- 2 June 2009
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 24 (9) , 2244-2254
Open AccessEffect of fetal or neonatal exposure to monobutyl phthalate (MBP) on testicular development and function in the marmoset
Fetal exposure of male rats to some phthalates induces reproductive abnormalities, raising concerns for similar effects in humans. In order to address this in a more appropriate animal model, the aim of the present studies was to investigate the effect of fetal/neonatal exposure to monobutyl phthalate (MBP) in a non-human primate, the marmoset. In particular, to determine if exposure resulted in effects at birth, or in adulthood, similar to those in male rats, and whether there was evidence for induction of carcinoma-in-situ (CIS) or testicular germ cell tumours (TGCT). Pregnant female marmosets were dosed from ∼7–15 weeks gestation with 500 mg/kg/day MBP and male offspring studied at birth (1–5 days; n = 6) or in adulthood (n = 5). In another study, newborn males (n = 5 co-twins) were dosed with 500 mg/kg/day MBP for 14 days, commencing at ∼4 days of age. Fetal exposure of marmosets to MBP did not affect gross testicular morphology, reproductive tract development or testosterone levels at birth, nor were germ cell number and proliferation, Sertoli cell number or germ:Sertoli cell ratio affected. In two of six MBP-exposed animals, unusual clusters of undifferentiated germ cells were found, but their significance is unclear. Neonatal MBP treatment did not affect germ cell numbers or differentiation. Fetal exposure to MBP did not affect testis size/morphology, germ cell numbers or fertility in adulthood. There was no evidence for CIS or TGCT. Fetal exposure of marmosets to MBP does not measurably affect testis development/function or cause testicular dysgenesis, and no effects emerge by adulthood. Some effects on germ cell development were found, but these were inconsistent and of uncertain significance.
- 1 September 2001
- Published by Bioscientifica in Reproduction
- Vol. 122 (3) , 419-429
Comparison of androgen receptor and oestrogen receptor beta immunoexpression in the testes of the common marmoset (Callithrix jacchus) from birth to adulthood: low androgen receptor immunoexpression in Sertoli cells during the neonatal increase in testosterone concentrations
- 1 September 2001
- Published by Bioscientifica in Reproduction
- Vol. 122 (3) , 419-429
Comparison of androgen receptor and oestrogen receptor beta immunoexpression in the testes of the common marmoset (Callithrix jacchus) from birth to adulthood: low androgen receptor immunoexpression in Sertoli cells during the neonatal increase in testosterone concentrations
- 1 June 1997
- Vol. 20 (3) , 171-9
Regulation of the secretion and synthesis of rat Sertoli cell SGP-1, SGP-2 and CP-2 by elongate spermatids.
The aim of this study was to investigate the effect of the absence of elongate spermatids (ES) from the rat seminiferous epithelium on the quantitative secretion and synthesis of the three major Sertoli cell secretory proteins--SGP-1, SGP-2 and CP-2. Seminiferous tubules (ST) were isolated (a) from normal 28-day-old rats, in which the most mature germ cell type is the round spermatid, (b) from normal adult rats at stages IX-XIV of the spermatogenic cycle, i.e. after spermiation, or at stages I-V and VI-VIII, when ES are still attached to the Sertoli cell, and (c) at stages VI-VIII from normal adult rats and from rats treated with methoxyacetic acid (MAA) in order to specifically deplete ES at these stages. Two-dimensional SDS PAGE combined with computerized image analysis was used to analyse 35S-methionine-labelled intracellular and secreted proteins. In the case of SGP-1 and SGP-2, almost all of the protein synthesized by ST was secreted. The total amount of both SGP-1 and CP-2 secreted by unstaged ST from immature rats was significantly lower than that secreted by unstaged ST from adult rats. The total amount of SGP-1 and CP-2 secreted by adult ST at stages IX-XIV of the spermatogenic cycle also declined dramatically compared to ST at earlier stages. The proportion of the total CP-2 synthesized by ST which was secreted also declined in all situations in which ES were absent from the seminiferous epithelium. The synthesis of only SGP-2 was changed by ES depletion from ST at stages VI-VIII, which was almost doubled compared to synthesis of this protein by ST from control rats. Our results suggest strongly that the secretion of SGP-1 and SGP-2 is via the constitutive pathway, and that regulation of these two proteins by ES is at the level of protein synthesis. In contrast, the regulation of CP-2 by ES is predominantly at the level of secretion, suggesting that this protein is secreted via a regulated pathway. Our findings add to the evidence showing that ES play a major role in the regulation of Sertoli cell function.
- 1 June 1997
- Vol. 20 (3) , 171-9
Regulation of the secretion and synthesis of rat Sertoli cell SGP-1, SGP-2 and CP-2 by elongate spermatids.
The aim of this study was to investigate the effect of the absence of elongate spermatids (ES) from the rat seminiferous epithelium on the quantitative secretion and synthesis of the three major Sertoli cell secretory proteins--SGP-1, SGP-2 and CP-2. Seminiferous tubules (ST) were isolated (a) from normal 28-day-old rats, in which the most mature germ cell type is the round spermatid, (b) from normal adult rats at stages IX-XIV of the spermatogenic cycle, i.e. after spermiation, or at stages I-V and VI-VIII, when ES are still attached to the Sertoli cell, and (c) at stages VI-VIII from normal adult rats and from rats treated with methoxyacetic acid (MAA) in order to specifically deplete ES at these stages. Two-dimensional SDS PAGE combined with computerized image analysis was used to analyse 35S-methionine-labelled intracellular and secreted proteins. In the case of SGP-1 and SGP-2, almost all of the protein synthesized by ST was secreted. The total amount of both SGP-1 and CP-2 secreted by unstaged ST from immature rats was significantly lower than that secreted by unstaged ST from adult rats. The total amount of SGP-1 and CP-2 secreted by adult ST at stages IX-XIV of the spermatogenic cycle also declined dramatically compared to ST at earlier stages. The proportion of the total CP-2 synthesized by ST which was secreted also declined in all situations in which ES were absent from the seminiferous epithelium. The synthesis of only SGP-2 was changed by ES depletion from ST at stages VI-VIII, which was almost doubled compared to synthesis of this protein by ST from control rats. Our results suggest strongly that the secretion of SGP-1 and SGP-2 is via the constitutive pathway, and that regulation of these two proteins by ES is at the level of protein synthesis. In contrast, the regulation of CP-2 by ES is predominantly at the level of secretion, suggesting that this protein is secreted via a regulated pathway. Our findings add to the evidence showing that ES play a major role in the regulation of Sertoli cell function.